v3.26.3
Stock-Based Compensation And Stock Repurchases
9 Months Ended
Sep. 30, 2026
Stock-Based Compensation And Stock Repurchases [Abstract]  
Stock-Based Compensation And Stock Repurchases Note 18 – Stock-Based Compensation and Stock Repurchases

Employee and Director Stock Incentive Plan

2020 Stock Incentive Plan

On December 5, 2024, the Company’s stockholders, upon recommendation of the Company’s board of directors, approved the Second Amendment to the 2020 Stock Incentive Plan, increasing the number of Class A Common Stock reserved for issuance under the 2020 Plan by an additional 3,500,000 shares.

Under the 2020 Plan, the Company may grant stock options and other share-based payment awards of our Class A Common Stock to eligible employees, directors and consultants. At September 30, 2026, there were 364,970 shares of Class A Common Stock available for issuance under the 2020 Plan. The Company’s Board will submit a proposal to the Company’s stockholders at the upcoming annual meeting of stockholders to approve an amendment to the 2020 Stock Incentive Plan to increase the number of shares of Class A Stock reserved for issuance thereunder by an additional 2,000,000 shares

Stock options are granted at exercise prices equal to the grant-date market prices and typically expire on either the fifth or tenth anniversary of the grant date, although the Company’s Compensation and Stock Options Committee (the “Compensation Committee”) may set different vesting times. In contrast to a stock option where the grantee buys our Company’s share at an exercise price determined on the grant date, a restricted stock unit (“RSU”) entitles the grantee to receive one share for every RSU based on a vesting plan, typically between one year and four from grant. As discussed further below, a performance component has been added to certain of the RSUs or options granted to management. At the time the options are exercised or RSUs vest and are settled, at the discretion of management, we may issue treasury shares or make a new issuance of shares to the option or RSU holder.

Stock Options

We have estimated the grant-date fair value of our stock options using the Black-Scholes option-valuation model, which takes into account assumptions such as the dividend yield, the risk-free interest rate, the expected stock price volatility, and the expected life of the options. We expensed the estimated grant-date fair values of options over the vesting period on a straight-line basis. Based on our historical experience, the “deemed exercise” of expiring in-the-money options and the relative market price to strike price of the options, we have not estimated any forfeitures of vested or unvested options.

For the quarter and nine months ended September 30, 2026, we recorded a compensation expense of $193,000 and $574,000, respectively, relating to our prior stock option grants. For the quarter and nine months ended September 30, 2025, we recorded a compensation expense of $197,000 and $762,000, respectively, relating to our prior stock option grants. At September 30, 2026, the total unrecognized estimated compensation expense related to non-vested stock options was $439,000, which we expect to recognize over a weighted average vesting period of 0.54 years. The intrinsic, unrealized value of all options outstanding vested and expected to vest, at September 30, 2026, was $1.5 million, as the closing price of our Class A Common Stock on that date was $1.85.

The following table summarizes the number of options outstanding and exercisable as of September 30, 2026, and December 31, 2025:

Outstanding Stock Options - Class A Shares

Number
‎
of Options

Weighted
‎
Average
‎
Exercise Price

Weighted
‎
Average
‎
Remaining
‎
Years of
‎
Contractual
‎
Life

Aggregate
‎
Intrinsic
‎
Value

Class A

Class A

Class A

Class A

Balance - December 31, 2024

1,707,412

$

1.63

9.44

$

—

Granted

2,396,708

1.41

—

—

Exercised

—

—

—

—

Forfeited

—

—

—

—

Balance - December 31, 2025

4,104,120

$

1.49

6.52

$

—

Granted

—

—

—

—

Exercised

—

—

—

—

Forfeited

(154,675)

—

—

—

Balance - September 30, 2026

3,949,445

$

1.46

5.79

$

—

Restricted Stock Units

The following table summarizes the status of RSUs granted to date as of September 30, 2026:

Restricted Stock Units

RSU Grants (in units)

Vested,

Unvested,

Forfeited,

Grant Date

Directors

Management

Total
‎
Grants

September 30,
‎
2026

September 30,
‎
2026

September 30,
‎
2026

Opening balance

339,438

1,222,252

1,561,690

1,447,524

—

114,167

April 11, 2023

—

413,536

413,536

326,197

54,362

32,977

April 21, 2023

—

237,719

237,719

201,195

26,966

9,558

April 28, 2023

—

20,427

20,427

14,549

4,330

1,548

April 27, 2026

—

702,016

702,016

—

702,016

—

Total

339,438

2,595,950

2,935,388

1,989,465

787,674

158,250

Time vested RSU awards to management typically vest 25% on the anniversary of the grant date and the remainder over a period of four years. Beginning in 2020, a performance component has been added to certain management equity grants, which vest on the third anniversary of their grant date based on the achievement of certain performance metrics. From 2021 onwards, RSUs have two vesting structures, which include time vesting and performance vesting. The majority of RSUs vest 75% evenly over a period of four years, with the remaining 25% contingent upon the achievement of certain performance metrics, vesting in full on the third anniversary of the date of the grant. In the case of our Chief Executive Officer, RSUs vest 50% evenly over a period of four years with the remaining 50%, contingent upon the achievement of certain performance metrics, vesting in full on the third anniversary of the grant date. In the second quarter of 2025, our Compensation Committee, upon the recommendation of our Chief Executive Officer and Board Chair, determined that due to liquidity management concerns, our Company would not pay cash bonuses for which our executive officers and other senior management may have been potentially eligible, and to issue stock options in lieu of such bonuses. Also, in 2024 and 2025, our Compensation Committee determined not to issue long term incentive stock options or RSUs.

For the quarter and nine months ended September 30, 2026, we recorded compensation expense of $236,000 and $627,000, respectively. For the quarter and nine months ended September 30, 2025, we recorded compensation expense of $194,000 and $759,000, respectively. The total unrecognized compensation expense related to the non-vested RSUs was $1.2 million as of September 30, 2026, which we expect to recognize over a weighted average vesting period of 0.28 years.